Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi rufie.
Came across this company yesterday whilst sifting through further software companies to potentially add to my portfolio
Shortlisted 5 to research in depth and this and Pelatro made it onto my buy list.
Like the growing turnover, high level of recurring income, strong balance sheet, percentage of shares held in big holdings, low mkt cap, current price in relation to 1 yr low-high and recent Director buys
For me Pelatro also ticks lots of these boxes so if you have already checked that one out you might like to
Also, if you check out my posts, you will see I am a big fan of Crimson Tide - proving to be a very very slow burner , but ..
I came across this recently, and I share f15jcm's concerns.... but, on balance, and given the recent results, I think it's worth a punt - so I got in at 28.5 this week. I know they'll lose some customers owing to the virus (bankruptcies etc), but there's clear potential to gain business from companies needing help with homeworking set-ups, changes to networks etc, not to mention the general swing to digitisation in companies, which will probably be fuelled by the whole lockdown experience. I also like the way they've publicly made a bullish objective ('1023') of EDITDA 10m by 2023 (see computerweekly). They've now got a little bit of cash, a huge revenue stream, and some director buys (not big, but notable)… so the shares are now looking very cheap (and the lowest they've been for many years). Any views welcome...
Adjusted EPS (1.1p) has gone backwards against H2 2019 (2p). Need to see more progress on the bottom line (and not just from acquisitions) before I consider buying.
Took at look at this company over the weekend. Valuation seems reasonable. Could come good (or itself be acquired) but I have a couple of concerns. Firstly the CEO is on quarter of a million. This seems ridiculous for a company of this size and someone of his limited experience (this is his first public company). Secondly, some of the reviews on glassdoor.co.uk from current/former members of staff are appalling. There seems to be HR issues and a lack of commitment from management to customer satisfaction, yet a strong focus on their own financial satisfaction. Is this another AIM gravy train?
I'll be looking over the results tomorrow.
Director Buying over last few months good enough for me. DYOR
System C Healthcare (SYS) has signed a contract with Gateshead Health NHS Foundation Trust for the deployment and operation of a core strategic patient administration and electronic patient record system. Under the terms of the contract, the IT solutions group will supply Gateshead Health with its Medway suite of patient administration and clinical software for a minimum seven year period. Shares in System C, which was founded in 1983, were flat at 70.5p.
System C agrees 70p a share bid Date: Thursday 03 Mar 2011 LONDON (ShareCast) - US-based McKesson Corporation is making a recommended offer of 70p a share in cash for healthcare IT provider System C Healthcare. The shares were trading at 46.5p prior to the announcement of bid talks. The bid values AIM-quoted System C at £87m. System C has net cash of £15.7m. Shareholders on the register on 25 February will still receive the interim dividend of 0.25p a share. McKesson already has acceptances totalling 33.3% of the System C share capital. System C joined AIM in June 2005 at a placing price of 54p a share, which valued the company at £47.7m. McKesson is a US IT business that has been involved in the healthcare IT sector in the UK since 1999. It is valued at more than $20bn and has annual revenues of $108.7m. As well as IT it distributes drugs and other healthcare products. The combined business will be able to provide a wide range of software and services to the NHS and private healthcare operations. The release of NHS trusts from central procurement of IT will provide opportunities to for the combined group to gain market share. The development of new software and declining revenues from older products pushed System C into loss into the six months to November 2010. That is why management believes that the longer-term prospects of the business will be enhanced as part of a more financially strong company.
http://www.investegate.co.uk/Article.aspx?id=201011110700089952V System C Healthcare plc 11th November 2010 System C wins MoD contract for healthcare software to support troops in Afghanistan. System C has been selected to supply its Medway family of healthcare software to support UK and NATO troops fighting in Afghanistan. The company will deploy its Medway Electronic Patient Record, clinical and patient management applications at the Ministry of Defence Medical Treatment Facility at Camp Bastion, Britain's main military base. Situated in Helmand Province, Camp Bastion's state of the art hospital treats civilians and Afghan nationals, as well as multi-national military personnel working across the country. Dr Ian Denley, chief executive of System C, said the company was proud to be selected for such an important job. "We are very pleased to have an opportunity to help support British and NATO troops in the role they are playing in Afghanistan", he said. The use of Medway will also become part of the MoD's Afghanistan pre -deployment training programme for operational medics and nurses from both the UK armed forces and Britain's NATO partners. System C will be working with Logica to train operational staff both in the UK, at the Army Medical Services Training Centre at Strensall, near York, and overseas. Logica is the prime contractor for the project and will ensure that System C's Medway products are successfully integrated with existing MoD software applications, in order to provide a first class clinical platform for the management and treatment of patients. System C will initially be supplying software for specialist applications such as bed management, clinical support tools, emergency department, intensive care, order communications, reporting, and patient administration
@ 41....... another big trade but with no movement in the sp
http://beta.investegate.co.uk/Article.aspx?id=201010221638199013U
yeah and you get a couple of tiny sells and the sp heads south! Im baffled by these latest trades its not like there negotiated, just normal o trades. Im also baffled why this company is so under valued? Do you think people veiw it as a pharma instead of a software company?
These big trades offen happen with this share and I like you have no reason why it does not shift the sp... Yet you will get two or three buys from PI's and the sp moves fine....
No change in SP..........how does that one work???
System C Healthcare PLC ("System C" or the "Company") System C makes gains in the independent treatment centre market. System C is pleased to announce that Care UK Ltd ("Care UK"), the independent healthcare provider, has gone live with the Medway PAS/EPR at six recently-acquired treatment centres. The deployments were successfully completed in a tight timeframe, with the final go-live being implemented in less than a month. The move has consolidated System C's position in the NHS independent treatment centre market. In addition to Care UK, the Company has contracts with Nations Healthcare and Circle Health. Independent treatment centres have been established to provide fast, same day or short-stay surgery and diagnostic procedures, traditionally in areas that have the longest waiting times within the NHS. Patients treated at an NHS Treatment Centre which is managed by an independent healthcare company are still NHS patients. Care UK set out to replace legacy IT systems in its six newly-acquired centres with a proven solution that was Choose & Book compliant. Care UK treats over 37,000 patients a year and claims to be the country's largest operator of NHS independent treatment centres. Medway Proxima, a version of System C's Medway PAS/EPR designed specifically for the independent healthcare market, was selected on the strength of its performance and track record. System C completed the first phase of the PAS replacement programme between May 2009 and January 2010. As well as delivering enhanced patient, referral and scheduling capabilities, Medway provided the sites with direct booking of their services using Choose & Book. Since then, phase 2 has been completed in a staged process, with each facility going live with full Medway, including patient tracking, clinical records, resource management and electronic discharge notifications. "As one of the UK's leading providers of elective surgery on behalf of the NHS, Care UK uses Choose & Book to promote its services to GPs, to provide information to patients and to enable them to make bookings", said Jardine Barrington-Cook, Care UK's head of business systems, healthcare. Dr Ian Denley, chief executive at System C, commented: "This was a rapid and high pressure deployment and we are delighted that it has been so successful."
lindoser, looks like some one is very happy to be buying at this level which has to be good news ....... :)
Another 2 x 1,000,000 buys just gone through. I just wonder who they are buying from as we have had very few sells recently.......someone seems to be stake building???
@ 40p Nice :)
Nice to see the big buys coming back again :)
Nice tick up again today :) 38 - 40.5
Nice 20k buy to start the day and interesting to see that I.G Markets have gone to phone orders only!!!!!
I wonder why the sudden rise today???? 37 - 39
Nice little rise here today :) 37 - 38.5